🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Yifan Pang

Levine Cancer Institute

ORCID: 0000-0002-8934-8251

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 4 papers. Top paper: “The ISHLT chronic lung allograft dysfunction consensus criteria are applicable to pulmonary chronic graft-versus-host disease”.

The ISHLT chronic lung allograft dysfunction consensus criteria are applicable to pulmonary chronic graft-versus-host disease

Blood Advances(2022)10.1182/bloodadvances.2021006885

N/A

0DataRank · unranked

16 citations

Ananth Charya, Michael B. Keller, Arlene Sirajuddin, Yi‐Ping Fu, Noa G. Holtzman +3 more

Severe autoimmune intravascular hemolytic anemia in patients receiving alemtuzumab for multiple sclerosis

Blood Advances(2022)10.1182/bloodadvances.2022008968

N/A

0DataRank · unranked

4 citations

Annapurna Saksena, Adolfo Diaz, Yifan Pang, Parth Desai, Parth Sharma

Chronic graft-versus-host disease is characterized by high levels and distinctive tissue-of-origin patterns of cell-free DNA

iScience(2023)10.1016/j.isci.2023.108160

N/A

0DataRank · unranked

8 citations

T. Andargie, Moon Kyoo Jang, Hyesik Kong, Woojin Park, Thomas Hill +7 more

Immunopathogenic mechanisms and modulatory approaches to graft-versus-host disease prevention in acute myeloid leukaemia

Best Practice & Research Clinical Haematology(2023)10.1016/j.beha.2023.101475

N/A

0DataRank · unranked

5 citations

Noa G. Holtzman, Yifan Pang